CCNT1 Antibody - #DF2288
| Product: | CCNT1 Antibody |
| Catalog: | DF2288 |
| Description: | Rabbit polyclonal antibody to CCNT1 |
| Application: | WB IHC |
| Reactivity: | Human, Mouse |
| Prediction: | Bovine, Horse, Sheep, Rabbit |
| Mol.Wt.: | 87 kDa; 81kD(Calculated). |
| Uniprot: | O60563 |
| RRID: | AB_2839514 |
Related Downloads
Protocols
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# DF2288, RRID:AB_2839514.
Fold/Unfold
CCN T1; CCNT; CCNT 1; Ccnt1; CCNT1_HUMAN; CDK9 associated C type protein; Cyc T1; Cyclin C related protein; Cyclin T; cyclin T1; Cyclin T1b; Cyclin-T; Cyclin-T1; CYCT 1; CycT1; HIVE1; Human immunodeficiency virus 1 expression; Human immunodeficiency virus type 1 (HIV 1) expression (elevated) 1; pTEFb subunit; Subunit of positive elongation transcription factor b;
Immunogens
- O60563 CCNT1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MEGERKNNNKRWYFTREQLENSPSRRFGVDPDKELSYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRFYMIQSFTQFPGNSVAPAALFLAAKVEEQPKKLEHVIKVAHTCLHPQESLPDTRSEAYLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKDLAQTSYFMATNSLHLTTFSLQYTPPVVACVCIHLACKWSNWEIPVSTDGKHWWEYVDATVTLELLDELTHEFLQILEKTPNRLKRIWNWRACEAAKKTKADDRGTDEKTSEQTILNMISQSSSDTTIAGLMSMSTSTTSAVPSLPVSEESSSNLTSVEMLPGKRWLSSQPSFKLEPTQGHRTSENLALTGVDHSLPQDGSNAFISQKQNSKSVPSAKVSLKEYRAKHAEELAAQKRQLENMEANVKSQYAYAAQNLLSHHDSHSSVILKMPIEGSENPERPFLEKADKTALKMRIPVAGGDKAASSKPEEIKMRIKVHAAADKHNSVEDSVTKSREHKEKHKTHPSNHHHHHNHHSHKHSHSQLPVGTGNKRPGDPKHSSQTSNLAHKTYSLSSSFSSSSSTRKRGPSEETGGAVFDHPAKIAKSTKSSSLNFSFPSLPTMGQMPGHSSDTSGLSFSQPSCKTRVPHSKLDKGPTGANGHNTTQTIDYQDTVNMLHSLLSAQGVQPTQPTAFEFVRPYSDYLNPRSGGISSRSGNTDKPRPPPLPSEPPPPLPPLPK
Predictions
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - O60563 As Substrate
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| K33 | Ubiquitination | Uniprot | |
| K100 | Ubiquitination | Uniprot | |
| T110 | Phosphorylation | Uniprot | |
| S117 | Phosphorylation | Uniprot | |
| T186 | Phosphorylation | Uniprot | |
| T278 | Phosphorylation | Uniprot | |
| S279 | Phosphorylation | Uniprot | |
| T282 | Phosphorylation | Uniprot | |
| S290 | Phosphorylation | Uniprot | |
| S292 | Phosphorylation | Uniprot | |
| T307 | Phosphorylation | Uniprot | |
| S340 | Phosphorylation | Uniprot | |
| K342 | Sumoylation | Uniprot | |
| K376 | Methylation | Uniprot | |
| K376 | Ubiquitination | Uniprot | |
| K380 | Acetylation | Uniprot | |
| K386 | Acetylation | Uniprot | |
| K386 | Ubiquitination | Uniprot | |
| S388 | Phosphorylation | Uniprot | |
| K390 | Acetylation | Uniprot | |
| K390 | Methylation | Uniprot | |
| K390 | Ubiquitination | Uniprot | |
| K404 | Acetylation | Uniprot | |
| K404 | Ubiquitination | Uniprot | |
| Y418 | Phosphorylation | Uniprot | |
| Y420 | Phosphorylation | Uniprot | |
| K476 | Acetylation | Uniprot | |
| K481 | Ubiquitination | Uniprot | |
| K492 | Acetylation | Uniprot | |
| S495 | Phosphorylation | Uniprot | |
| S499 | Phosphorylation | Uniprot | |
| S529 | Phosphorylation | Uniprot | |
| S531 | Phosphorylation | Uniprot | |
| K546 | Ubiquitination | Uniprot | |
| S549 | Phosphorylation | Uniprot | |
| S564 | Phosphorylation | P53350 (PLK1) | Uniprot |
| S570 | Phosphorylation | Uniprot | |
| S577 | Phosphorylation | Uniprot | |
| K590 | Ubiquitination | Uniprot | |
| S629 | Phosphorylation | Uniprot | |
| Y690 | Phosphorylation | Uniprot | |
| K707 | Acetylation | Uniprot |
Research Backgrounds
Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin-T1) complex, also called positive transcription elongation factor B (P-TEFb), which is proposed to facilitate the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNA Pol II).
(Microbial infection) In case of HIV or SIV infections, binds to the transactivation domain of the viral nuclear transcriptional activator, Tat, thereby increasing Tat's affinity for the transactivating response RNA element (TAR RNA). Serves as an essential cofactor for Tat, by promoting RNA Pol II activation, allowing transcription of viral genes.
Nucleus.
Ubiquitously expressed.
Cyclin-T1 is the predominant cyclin that associates with CDK9 to form a heterodimer called P-TEFb. P-TEFb forms a complex with AFF4/AF5Q31. Component of a complex which is at least composed of HTATSF1/Tat-SF1, P-TEFb complex, RNA pol II, SUPT5H, and NCL/nucleolin. Component of the 7SK snRNP complex at least composed of P-TEFb (composed of CDK9 and CCNT1/cyclin-T1), HEXIM1, HEXIM2, BCDIN3, SART3 proteins and 7SK and U6 snRNAs. Interacts with BRD4, targets chromatin binding. Interacts with JMJD6. Interacts with MDFIC. Interacts with HSF1. Interacts with HTATSF1. Interacts with AFF4. Interacts with TBX21.
(Microbial infection) Interacts with the transactivation region of HIV-1, HIV-2 and SIV Tat.
Belongs to the cyclin family. Cyclin C subfamily.
Research Fields
· Human Diseases > Cancers: Overview > Transcriptional misregulation in cancer.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.